YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
4.730
-0.100 (-2.07%)
At close: Nov 17, 2026, 4:00 PM EST
4.640
-0.090 (-1.90%)
After-hours: Nov 17, 2026, 4:29 PM EST

YD Bio Statistics

Total Valuation

YD Bio has a market cap or net worth of $335.03 million. The enterprise value is $332.38 million.

Market Cap335.03M
Enterprise Value 332.38M

Important Dates

The last earnings date was Monday, August 31, 2026, after market close.

Earnings Date Aug 31, 2026
Ex-Dividend Date n/a

Share Statistics

YD Bio has 70.83 million shares outstanding. The number of shares has decreased by -13.49% in one year.

Current Share Class 70.83M
Shares Outstanding 70.83M
Shares Change (YoY) -13.49%
Shares Change (QoQ) n/a
Owned by Insiders (%) 76.79%
Owned by Institutions (%) 0.72%
Float 16.19M

Valuation Ratios

The trailing PE ratio is 1,079.42.

PE Ratio 1,079.42
Forward PE n/a
PS Ratio 277.96
Forward PS n/a
PB Ratio 77.01
P/TBV Ratio 172.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 1,117.94
EV / Sales 275.82
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.23, with a Debt / Equity ratio of 0.00.

Current Ratio 5.23
Quick Ratio 2.70
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -360.63%
Return on Capital Employed (ROCE) -72.88%
Weighted Average Cost of Capital (WACC) 3.56%
Revenue Per Employee $82,621
Profits Per Employee $20,384
Employee Count 15
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -24
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.39% in the last 52 weeks. The beta is -0.13, so YD Bio's price volatility has been lower than the market average.

Beta (5Y) -0.13
52-Week Price Change -61.39%
50-Day Moving Average 5.55
200-Day Moving Average 5.17
Relative Strength Index (RSI) 41.52
Average Volume (20 Days) 97,712

Short Selling Information

The latest short interest is 187,405, so 0.26% of the outstanding shares have been sold short.

Short Interest 187,405
Short Previous Month 192,222
Short % of Shares Out 0.26%
Short % of Float 1.16%
Short Ratio (days to cover) 1.12

Income Statement

In the last 12 months, YD Bio had revenue of $1.24 million and earned $305,762 in profits. Earnings per share was $0.00.

Revenue1.24M
Gross Profit 366,845
Operating Income -6.55M
Pretax Income 305,738
Net Income 305,762
EBITDA -6.34M
EBIT -6.55M
Earnings Per Share (EPS) $0.00
Full Income Statement

Balance Sheet

The company has $2.66 million in cash and $5,002 in debt, with a net cash position of $2.66 million or $0.04 per share.

Cash & Cash Equivalents 2.66M
Total Debt 5,002
Net Cash 2.66M
Net Cash Per Share $0.04
Equity (Book Value) 4.47M
Book Value Per Share 0.06
Working Capital 4.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.26 million and capital expenditures -$1.45 million, giving a free cash flow of -$8.70 million.

Operating Cash Flow -7.26M
Capital Expenditures -1.45M
Depreciation & Amortization 210,600
Net Borrowing n/a
Free Cash Flow -8.70M
FCF Per Share -$0.12
Full Cash Flow Statement

Margins

Gross margin is 29.60%, with operating and profit margins of -528.72% and 24.67%.

Gross Margin 29.60%
Operating Margin -528.72%
Pretax Margin 24.67%
Profit Margin 24.67%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YD Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 13.49%
Shareholder Yield 13.49%
Earnings Yield 0.09%
FCF Yield -2.53%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

YD Bio has an Altman Z-Score of 67.4 and a Piotroski F-Score of 1.

Altman Z-Score 67.4
Piotroski F-Score 1